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Abstract
We investigated the link between epigenome-wide methylation aberrations at birth and genomic transcriptional changes
upon allergen sensitization that occur in the neonatal dendritic cells (DC) due to maternal asthma. We previously
demonstrated that neonates of asthmatic mothers are born with a functional skew in splenic DCs that can be seen even in
allergen-naı¨ve pups and can convey allergy responses to normal recipients. However, minimal-to-no transcriptional or
phenotypic changes were found to explain this alteration. Here we provide in-depth analysis of genome-wide DNA
methylation profiles and RNA transcriptional (microarray) profiles before and after allergen sensitization. We identified
differentially methylated and differentially expressed loci and performed manually-curated matching of methylation status
of the key regulatory sequences (promoters and CpG islands) to expression of their respective transcripts before and after
sensitization. We found that while allergen-naive DCs from asthma-at-risk neonates have minimal transcriptional change
compared to controls, the methylation changes are extensive. The substantial transcriptional change only becomes evident
upon allergen sensitization, when it occurs in multiple genes with the pre-existing epigenetic alterations. We demonstrate
that maternal asthma leads to both hyper- and hypomethylation in neonatal DCs, and that both types of events at various
loci significantly overlap with transcriptional responses to allergen. Pathway analysis indicates that approximately 1/2 of
differentially expressed and differentially methylated genes directly interact in known networks involved in allergy and
asthma processes. We conclude that congenital epigenetic changes in DCs are strongly linked to altered transcriptional
responses to allergen and to early-life asthma origin. The findings are consistent with the emerging paradigm that asthma is
a disease with underlying epigenetic changes.
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Introduction
Allergy and, more specifically, allergic asthma, often starts early
in life [1–6]. The onset of the disease is crucially linked to the
decision-making point in the immune system, when the machinery
of dendritic cells (DC) determines whether or not the protein is
recognized as allergen for presentation to T-cells in a particular
context [7–10]. This leads to development of a Th2 milieu that
later maintains the allergy process [11–13]. The decision-making
mechanism in the DCs is unknown; this hinders our understanding
of how allergy originates. In our mouse model [14] genetically and
environmentally identical neonates of asthmatic mothers develop
allergy more readily compared to control counterparts coming
from normal parents or asthmatic fathers. This model mirrors
epidemiologic studies in humans [15–19] and indicates non-
genetic and non-environmental transmission of asthma risk from
the mother. The asthma-at-risk pups develop asthmatic symptoms
in response to an intentionally suboptimal protocol (lower allergen
dose/fewer administrations) in contrast to normal pups which do
not develop symptoms under the same conditions. In adoptive
transfer experiments [20] DCs from asthma-at-risk pups to normal
pups, but not macrophages, CD4 T-cells, or DC-depleted
splenocytes, caused increased susceptibility to asthma in the
recipients, indicating that DCs of asthma-at-risk pups are skewed
early in life to induce allergic responses.
In this study we have tested a hypothesis that maternal ‘‘risk
inheritance’’ in our mouse model is conveyed via epigenetic
changes occurring in pups prenatally or in early postnatal period.
We chose splenic DCs as the object of our study because of their
crucial role in adaptive immune responses, and because they are
sufficient to cause an asthma-at-risk phenotype in the adoptive
transfer experiments discussed above [20]. We assessed whole
genome epigenetic and transcriptional changes in dendritic cells
from normal and asthma-at-risk pups prior to (naı¨ve pups) and
after antigen sensitization (sensitized pups). The hypothesis was
that maternal allergy induces epigenetic changes that can be
detected at birth, and prior to allergen sensitization. We further
postulated that, for these DNA methylation changes to lead to
transcriptional difference in response to allergen, they would be
found in key regulatory areas (e.g. promoters and CpG islands) of
relevant genes. We therefore sought to detect and characterize
DNA-wide methylation changes, and then to match them to
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differentially expressed transcripts. We further postulated that
these altered methylation sites are likely to be linked causally to an
early-life asthma risk phenotype. A final prediction tested was that
‘activation’ or ‘priming’ of the DC with allergen sensitization
would reveal more transcriptional differences than would be found
in unstimulated DCs from allergen-naive neonates.
Results
Asthma-at-risk DCs show large-scale DNA methylation
differences compared to control
We found a large number of probes differentially methylated
between naı¨ve normal and asthma-at-risk pups. In contrast, only a
small number of genes showed differential transcription under
these conditions. However, a much greater number of differen-
tially expressed genes was detected in DCs from allergen-
stimulated pups. We found substantial overlap between genes
differentially expressed in allergen-stimulated pups, and those
containing differentially methylated probes in naı¨ve pups. Pathway
analysis of the overlapping genes revealed that a majority belong
to several important transcriptional networks including those
regulated by well-known inflammatory factors such as Nfkb and
Stat1, as well as networks associated with cell differentiation and
activation.
Specifically, we have analyzed a dataset (GSE13380) obtained
using a Switchgear platform to identify differentially methylated
regions (DMRs) in mouse dendritic cell DNA from normal mice
and asthma-at-risk mice (offspring of normal and asthmatic
mothers, respectively). The analysis revealed significant differences
in methylation patterns between the two groups. Out of 345,225
experimental probes, we have found 23,477 probes (,6.8%)
differentially unmethylated in normal samples and 28,615
(,8.3%) differentially unmethylated in asthma using a false
discovery rate (FDR) of 0.05. 88,445 probes (,26%) were found
to be unmethylated in both groups. We followed by analyzing the
results obtained from each group separately. We imposed
additional restrictions to select the most relevant DMRs. First,
we required that higher methylated samples for each DMR had
log2 fold change .0.5 thus removing probes with ambiguous calls.
Second, we have removed DMRs with absolute difference in log2
fold change between groups ,0.3, to select the regions where the
difference would more likely to be biologically relevant. This
filtering resulted in 4,441 probes that we consider unmethylated in
normal samples but methylated in asthma-at-risk, and 8,030
probes unmethylated in asthma-at-risk but methylated in normal
samples. These DMRs were mapped respectively to 4,785 and
7,527 transcripts and/or promoters (defined as 21000 to +500 bp
relative to the transcription start site), out of total 24,364
transcripts that had methylation probes mapping either within
the transcript or in its promoter region.
Transcriptional differences in naı¨ve DCs are minor but
correlate with epigenetic changes
To facilitate comparison between gene expression and DNA
methylation data, we combined methylation and expression data
for 9,964 transcripts which were represented on both platforms.
Relevant numbers of differentially expressed (DE) transcripts
which contain DMRs are schematically represented in Fig. 1.
Analysis of the Affymetrix expression data identified 60
differentially expressed (DE) transcripts in naı¨ve DC (FDR 0.05
and fold change 1.25 or greater) out of 16,963 transcripts
represented on the array. Methylation data was available for 33
of the 60 transcripts. We found that only 18 transcripts were both
differentially expressed and differentially methylated in naı¨ve DC
(55% of transcripts for which both expression and methylation
data are available). Three transcripts contained both hypo- and
hyper-methylated DMRs. The majority (2/3) of the transcripts
changed expression in the direction predicted by a corresponding
shift in DNA methylation (following the predominant paradigm
that lower methylation is associated with higher expression). The
expression changes were minor in magnitude for these targets.
Pathway analysis of the 18-target list revealed three canonical
pathways enriched with differentially-expressed and differentially-
methylated genes in naı¨ve DC: the Jak-Stat pathway, which is
mostly down-regulated in asthma-at-risk DC (and remains
significant even if only down-regulated genes are analyzed), the
RAR-alpha pathway (Fig. 2), and a cluster of genes in the VEGF
pathway. Remarkably, 15 out of 18 transcripts belong to the
interaction network focused on the regulation of IL-6 (Fig. 2), a
cytokine crucial in early asthma development [21]. This suggests
that deregulation of the IL-6 methylation profile could play an
important role in a pro-allergic skew of allergen-naı¨ve DCs, and
possibly is an early indication of asthma predisposition. The fact
that the 18 genes belong to pathways relevant to asthma is
encouraging and supports the biological significance of our
analysis. It is noteworthy however, that majority of DE genes in
these pathways are not differentially expressed in stimulated DC
(compare Figs. 2 and 3) suggesting they may not play role in the
allergen response past the sensitization.
Hence, analysis of allergen-naive samples identified multiple
epigenetic changes induced by maternal allergy but these were not
linked to major background transcription alterations on their own
(with the exception of a minor transcriptional shift in the IL-6
signaling pathway). These findings can now be compared to what
was found after allergen stimulation.
Upon allergen sensitization robust transcriptional
changes are seen among transcripts showing epigenetic
alterations at birth
We have found a substantially greater number of differentially
expressed transcripts after allergen stimulation. 707 transcripts
were differentially expressed overall in asthma-at-risk vs naive DC
(FDR 0.05 and fold change 1.25 or greater), and 347 of them were
present in the methylation ‘hit list’ as differentially methylated in
asthma-at-risk vs naive DC. 62 of the transcripts were associated
with unmethylated DMRs in normal naı¨ve DC, and 101 in
asthma-at-risk (25 transcripts contain both). Similar to naı¨ve DC, a
group of transcripts contained both hyper- and hypo- methylated
DMRs. We observed similar numbers of up- and down-regulated
transcripts in the stimulated group, with slightly more up-
regulation in hypo-methylated subgroup (Fig. 1).
About one-third of the DE and DM transcripts from allergen-
stimulated DCs interact functionally with each other, some of
them with multiple interactions (Fig. 3). Among them are a
number of genes previously found to be involved in allergic
responses, such as Runx2, MMP9, CXCR4 and 5, IL-12, beta-
adrenoreceptor, cadherin, AP1, VEGF-R1, etc. While many
pathways are affected by transcriptional changes in stimulated
DC, the focal points of the changes appear to be transcription
factors. The top 30 significant transcriptional networks include
several subunits of NFkB, and several STAT genes, which are
involved in regulation of immune response. However, other
transcription networks, associated with more general functions
such as cell proliferation and differentiation are also prominent.
Because each gene is targeted by several probes in the
methylation array, we sought to determine whether there are
targets that have both hyper- and hypomethylated areas, and we
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identified only 8 such genes for the naı¨ve (Table S1) and 61 genes
for allergen-sensitized mice (Table S2).
For allergen-sensitized mice most of the methylation changes
occurred either within promoters of genes or overlapped with a
nearby CpG island; a small proportion of probesets (,26%) were
mapped to areas that are unlikely to include key transcription
regulation elements (Fig. 4).
The presence of DE transcripts with multiple DMRs altered in
opposing directions (hypo- and hyper-) presented an opportunity
to analyze the role of relative position of CpG sites in altering
transcription. 65 such transcripts were found for allergen-
sensitized DC samples with FDR for DE 0.05 (no restriction on
fold change). The DMRs associated with these transcripts were
categorized as overlapping with promoter, CpG island, both or
neither. A DMR was selected as ‘‘influential’’ if its methylation
changed in accordance with subsequent change in transcription. If
more than one ‘‘influential’’ DMR was present, one was picked
with following priority: Promoter and CpG island.Promo-
ter.CpG island.neither. While this approach is biased against
CpG islands, only two transcripts were affected (having separate
‘‘influential’’ probes in promoter only and in CpG island only),
both down-regulated.
Approximately L of the transcripts have the potentially
‘influential’ probes within expected regulatory regions – promoters
or CpG islands or both (72% of up-regulated transcripts, 76% of
down-regulated, and 74% overall, Fig. 4). In more than 1/3 of the
transcripts such probes are located in CpG islands within
promoter region (43%, 35%, and 38% respectively). Interestingly,
CpG islands outside of promoter regions (but within the body of a
transcript) appear to influence transcription quite often, especially
in case of down-regulated transcripts (30%, even with minor bias
against such probes). Ultimately, epigenetic alterations at several
regions simultaneously may be necessary for a subsequent
transcriptional shift.
Genes that were downregulated were more likely to have
aberrant methylation in the CpG islands than in the promoter
(30% vs 11% in islands and 11% vs 18% in promoters). This
finding supports the recent paradigm that methylation of the CpG
islands has a stronger transcriptional significance than methylation
of promoter sequences.
In summary, upon allergen sensitization the DCs of asthma-at-
risk neonates show significant transcriptional change compared to
controls; the majority of up- or downregulated genes have pre-
existing methylation changes (at birth) indicating that maternal
transmission of asthma risk associated with the dysfunction of DCs
is largely an epigenetic phenomenon.
Discussion
Recent publications demonstrate special importance of the
epigenetic changes acquired during perinatal development to the
future health. Maternal asthma transmits an increased asthma risk
to neonates, both in humans and in our mouse model. Others
show in a similar model that such risk may be transmitted
transgenerationally, and postulate epigenetic mechanisms [22–24].
We have previously identified neonatal DC as a critical cell that
conveys this asthma risk to normal recipients in adoptive transfer
experiments [20].
This report demonstrates that neonates at-risk of asthma are
born with substantial genome-wide DNA methylation changes in
their DCs due to maternal allergy. We based our hypothesis on the
paradigm that allergen sensitization in responsive subjects leads to
genome-wide changes in transcription of immune cells as they
activate. The premise of this study was that many of these changes
are preceded (and potentially caused) by epigenetic alterations in
key regulatory sequences that arise as a result of maternal
influence.
As we predicted, transcriptional differences in the allergen-naı¨ve
neonates are minimal. While the number of statistically significant
DE transcripts (n = 60) is not negligible, for the majority of these
transcripts (80%) the expression difference between normal and
asthma-at-risk DC does not exceed 1.5 fold, and only one
transcript (Fkbp5) changes more than two-fold. One of the
limitations of such small differences detected on a genome-wide
Figure 1. Number of transcripts differentially methylated and differentially expressed between asthma-at-risk DCs and controls.
doi:10.1371/journal.pone.0070387.g001
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Figure 2. Transcripts showing both DNAmethylation and expression changes between naı¨ve normal and asthma-at-risk DCs form a
small interaction network focused on regulation of a pleiotropic cytokine IL-6. Interacting factors are depicted in various shapes
depending on their biological nature, connecting arrows indicate known links. Blue circles indicate transcripts down-regulated in asthma-at-risk DCs,
red – up-regulated.
doi:10.1371/journal.pone.0070387.g002
Figure 3. Interaction network of transcripts with significant change in DNA methylation at birth that show significant
transcriptional change later in life upon the first encounter with allergen. Interacting factors are depicted in various shapes depending
on their biological nature, connecting arrows indicate known links. Blue circles indicate transcripts down-regulated in asthma-at-risk DCs, red – up-
regulated.
doi:10.1371/journal.pone.0070387.g003
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scale is difficulty reproducing them in other models and other
species. This relatively small magnitude of expression changes is in
agreement with the absence of phenotypical difference between
naı¨ve normal and asthma-at-risk pups, including absence of any
immunophenotypic differences of the surface of DCs itself that as
we reported earlier. Among differentially expressed are the genes
involved in the IL-6 pathway due to their participation in Jak-Stat
and Rar-alpha signaling pathways; they seem to be the only early
indicators of a pro-allergic skew.
However, upon allergen sensitization, strong transcriptional
differences are seen in genes that also had methylation aberrations
at birth. For the allergen-stimulated DCs, we found over 700 DE
transcripts; more than 40 of them were over 2-fold different, and
several showed as much as a 4-fold change. Juxtaposing the
methylation and expression data shows that a large percentage (55
for naı¨ve DCs and 40 for allergen-stimulated DCs) of DE
transcripts come from genes with pre-existing methylation
changes. It is also worth noting that for the allergen-sensitized
DCs, transcriptional changes were not limited to genes with
detectable methylation changes at birth. This is plausible in light of
the prominent involvement of transcription factors in our
observations suggesting that deregulation of transcriptional net-
works has its own effects on many targets that are not
epigenetically altered, and previous data reporting constitutively
unmethylated genes.
An interesting aspect is that approximately the same number of
genes change in compliance with the biological paradigm that
demethylation leads to increased expression (56), as the number
that change ‘discordantly’ in the opposite direction (53), suggesting
that either methylation is but one of the factors in the complex
mechanisms of transcriptional regulation, or that methylation in
some sites is more transcriptionally important than in adjacent
sites. Thus, some of the DMRs may be located at non-regulatory
sequences, and others may be unaffected by the putative signaling
pathways activated in allergy response. On the other hand, not all
DE genes harbor differentially methylated sites, implying that they
are regulated by other means.
The direct interactions network in Fig. 3 identifies genes that are
likely causative for the early-life asthma origin, based on this
analysis and our prior work [20,25]. Among these 57 genes which
evidently interact with each other very well, there are 29 that we
found have a known role in asthma or allergic inflammation. They
are: Klf6 (Gene ID: 23849) [29], Lamin A/C (Gene ID: 16905)
[30], E4BP4 (Gene ID: 18030) [31], Eomesodemin (Gene ID:
13813) [32], GATA-3 (Gene ID: 14462) [33], T-bet (Gene ID:
57765) [34], CXCR5 (Gene ID: 12145) [35], SOCS3(Gene ID:
12702) [36], Lck (Gene ID: 16818) and FGR(Gene ID: 14191)
[37], MKP-1 (Gene ID: 19252) [38], ALOX12(Gene ID: 11684)
[39], RhoB (Gene ID 11852) [40], G0/G1 switch 2(Gene ID:
14373) relevant to cell proliferation, NOXA (Gene ID: 58801)
[41], Dematin (Gene ID: 13829) [42], PKC-alpha (Gene ID:
18750) [43], TRPC6 (Gene ID: 22068) [44], VEGFR-1(Gene ID:
14254) [45], CXCR4 (Gene ID: 12767) [46], Beta-2 adrenergic
receptor(Gene ID: 11555) [47], Il12a (Gene ID: 16159) [48], NPY
(Gene ID: 109648) [49], Slit2 (Gene ID: 20563) [50], Col1a2
(Gene ID: 12843) [51], Cxcl12 (Gene ID: 20315) [52], MMP-9
(Gene ID: 17395) [53], IBP3 (Gene ID: 16009) [54], Kallikrein 4
(Gene ID: 56640) [55]. The rest of the factors (genes) are less well
characterized and comprise opportunities for future research.
It remains unclear what role is played by the remaining
methylation aberrations not studied here, i.e. changes outside of
the coding or regulatory areas and changes in the genes that do
not transcriptionally respond. These DMR may be either a
secondary effect of changes in cell functionality, or a ‘bystander’
para-phenomenon that plays no role, or may have unknown
regulatory consequences that remain to be discovered. A few
methodological limitations of our study should also be mentioned:
first, mouse models of disease do not necessarily reproduce every
detail of human disease; second, genome-wide studies carry
inherent risks related to multiplicity of comparisons; third,
information provided by pathway analysis methods relies on
known interactions between factors, which means the scope may
be limited by published knowledge.
Conclusion: Maternal asthma leads to epigenetic change in DCs
of the neonate, and this is linked to their skewed state at birth
towards producing allergy responses upon encounter with allergen.
The methylation changes are diverse and complex: they include
both hyper and hypomethylation; many are associated with
changed expression, but some are not; conversely, some expression
changes are and some are not directly linked to methylation status.
This brings new light to the epigenetic origins of asthma,
demonstrating that they are not as simple as we may have hoped.
These data also highlight the need for methods for targeted
manipulation of the epigenetic status of genes to allow precise
testing of causal roles in functional effects.
Methods
Animals
BALB/C mice were obtained from Charles River Laboratories
(Cambridge, MA). Animal care complied with the Guide for the
Care and Use of Laboratory Animals and all experiments were
approved by the Institutional Review Board/IACUC: Harvard
Center for Comparative Medicine.
Exposure protocol
The animal protocol uses is based on previous studies
[14,20,25–27]. Briefly, maternal sensitization is achieved by initial
i.p. injections of 5 mg OVA with 1 mg alum in 0.1 ml PBS into
mice at 3 and 7 days of age. After weaning, female mice are
exposed to aerosols of allergen (3% (w/v) OVA (grade V, Sigma-
Aldrich) in PBS, pH 7.4) for 10 min on 3 consecutive days at 4, 8,
and 12 wk of age, and then mated with normal male mice. The
Figure 4. In the allergen stimulated group DCs most genes with
significant change in transcription (DE) had altered methyla-
tion either in the promoter (14%), CpG island (22%) or both
(38%) (of all overalpping DMR-DE). Only 26% of the genes had
changes elsewhere in the body of the transcript.
doi:10.1371/journal.pone.0070387.g004
Epigenome and Transcriptome of Asthma-Risk DCs
PLOS ONE | www.plosone.org 5 August 2013 | Volume 8 | Issue 8 | e70387
aerosol exposure is performed within individual compartments of a
mouse pie chamber (Braintree Scientific, Braintree, MA) using a
Pari IS2 nebulizer (Sun Medical Supply, Kansas City, KS)
connected to air compressor (PulmoAID; DeVilbiss, Somerset,
PA). These female mice were shown to consistently have strongly
increased AHR and AI [25–27].
Typically to confirm the maternal transmission effect, offspring
of these allergic and of control PBS-challenged mice are subjected
to ‘suboptimal’ protocol. On day 4 after birth newborns receive a
single i.p. injection of OVA with alum (an intentionally suboptimal
dosage that normally does not result in significant AHR and AI in
offspring of normal intact or PBS-challenged mothers). On days
13–15 of life, these baby mice are exposed to aerosolized OVA, as
above. In this report only the ‘quality-assurance’ neonates were
subjected to this testing. For genomic and epigenomic profiling
used in this work the neonatal DCs were harvested at d. 14 from
either allergen-naı¨ve neonates (‘‘Naive DC’’ in Figure 1), or from
those that received a single sensitization injection of OVA+alum,
but not the aerosols (‘‘Allergen stimulated DC’’ in Figure 1).
Cell purification
Splenic dendritic cells (DCs) were prepared from collagenase D
-treated (Roche) sterile cell suspensions using positive selection
(retaining of CD11c+ cells) via the MACS magnetic bead system
(Miltenyi Biotec, Auburn, CA). Purity was routinely monitored via
flow cytometry (FACSCanto II, Beckton-Dickinson) by labeling
for CD11c and MHC-II. More than 95% of the purified cells were
double positive for these antigens, and viability was .93% by
propidium iodide or trypan blue staining. After purifications the
cells were washed 2 times in LPS-free sterile PBS with 5% BSA
and once in pure ice-cold LPS-free sterile PBS.
Isolation of nucleic acids and PCR
DNA and RNA were isolated using Qiagen DNEasy and
RNEasy kits, respectively, in complete adherence with the
instructions. RNA isolations included the optional DNAse
digestion step. Quality of the RNA was tested spectrophotomet-
rically via Nanodrop and confirmed in real-time PCR for beta-
actin prior to submission. For quality control and validation
purposes (Figure S1) the real-time PCR protocol was based on the
SYBR Green assay (Bio-Rad) running 95uC - 109, then 35 cycles
of 95uC - 200; 55uC - 250; 72uC - 200, then standard melt curve.
Epigenomic profiling
The DNA methylation assay was performed by Switchgear
Genomics (Menlo Park, CA), and the data is publicly available in
GEO (GSE13380). The dataset consists of 18 two-color chipsets (9
biological repeats from the offspring of normal mothers, and 9
from the offspring of asthmatic mothers). Each chipset contains
386,009 probes out of which 345,225 are experimental probes,
and the rest are control probes, presumably not changing with
treatment.
The DNA from each sample was divided in two equal parts, and
one part was treated with methylation sensitive endonuclease.
Subsequently, treated part of each sample was labeled with Cy3
dye, and untreated part with Cy5, and both were hybridized on
the same chip.
Epigenomic data analysis
Raw fluorescence intensity values provided by Switchgear
Genomics were used in the analysis, performed with Bioconductor
package limma [28]. Two chipsets (one of a normal sample, and
one of asthma-at-risk) were excluded from the analysis on the basis
of their small interquartile difference, likely due to endonuclease
treatment failure. Remaining 16 samples were first normalized
within arrays using the ‘‘control’’ method. This method fits a
global loess curve through a set of control (non-changing) spots,
and applies the curve to the rest of the spots. The quantile method
was used for between-arrays normalization.
After filtering out control probes, linear modeling approach was
used for differential methylation inference, with subsequent fitting
of the contrasts for methylation in normal samples, methylation in
asthma-at-risk samples, and difference in methylation between
normal and asthma-at-risk samples. The null hypothesis for the
first two contrasts was that a probe is methylated, and for the third
contrast that there is no difference between normal and asthmatic
samples. Finally, t statistics for each probe were moderated using
Bayes empirical method, and corresponding p-values adjusted for
multiple testing according to Benjamini-Hochberg. Probes with
adjusted p-values 0.05 or less and log2 fold change of 0.5 or
greater were selected as unmethylated in respective groups. 23 477
such probes were identified as demethylated only in normal
samples, and 28 615 probes only in asthmatic samples. These
probes were further filtered applying following conditions: 1) the
log2 fold change for methylated group ,0.5; 2) absolute difference
in log2 fold change between groups .0.3. Resulting lists of probes
were mapped to transcripts, promoter regions (21000 to +500
bases from TSS), and CpG islands (UCSC Genome Browser,
release mm8) with Bioconductor packages GenomicFeatures,
GenomicRanges, and IRanges (www.bioconductor.org).
Expression profiling
Gene expression was assayed on the Affymetrix mouse gene
chip Mouse430A 2.0 (Affymetrix, Santa Clara, CA) at the Dana
Farber Cancer Institute hybridization facility. Two datasets were
used in the analysis. Set 1 consists of 4 groups: naı¨ve normal, naı¨ve
asthma-at-risk, allergen stimulated normal and allergen stimulated
asthma-at-risk; 4 biological replicates in each group. Set 2 consists
of two groups – allergen stimulated normal and allergen stimulated
asthma-at-risk, 5 biological replicates each, NuGEN amplified.
Expression data analysis
One array from each of the sets was excluded as outlier based
on principle component analysis. The datasets were preprocessed
separately using quantile normalization and median polish
summarization steps. We used alternative cell definition file (cdf)
- ‘‘mouse430a2mmrefseq’’ – available from Brainarray microarray
lab at the University of Michigan (http://brainarray.mbni.med.
umich.edu/brainarray) for summarization. After preprocessing,
differential expression inference was performed with Bioconductor
package limma. Comparisons of interest were: naı¨ve normal versus
naı¨ve asthma-at-risk, and stimulated normal versus stimulated
asthmatic (offspring of asthmatic mothers). T statistics for each
probeset were moderated using Bayes empirical method, and p-
values adjusted for multiple testing according to Benjamini-
Hochberg.
Pathway analysis
Pathways analysis was performed with Metacore software
(GeneGo Inc.). Annotated lists of genes of interest (DMRs
overlapping to transcriptionally changed targets in naive DC,
and DMRs overlapping to transcriptionally changed targets in
allergen-stimulated DC) were uploaded to the portal and analyzed
separately using the ‘‘direct interactions’’ algorithm. This analysis
visualizes all known direct interactions of the genes in a list to each
other, according to the proprietary Metacore database. We have
used the default options, i.e. no filtering by tissue or disease.
Epigenome and Transcriptome of Asthma-Risk DCs
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Supporting Information
Figure S1 PCR validation of the microarray data. We
validated 5 semi-randomly selected targets from the microarray
results, both up- and down-regulated and unchanged, via real-time
PCR. Microarray data represent fold change of ‘‘asthma’’ vs
‘‘normal’’ expression in RMA values; PCR data represent the SYBR
green assay results from the same RNA samples; Cq values for each
target were normalized to 18S RNA and similar fold change of
‘‘asthma’’ vs ‘‘normal’’ expression was obtained. n = 5/group.
(TIF)
Table S1 Naı¨ve DCs.
(DOC)
Table S2 Allergen-sensitized DCs.
(DOC)
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